Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aerobic dehydrogenases that are flavoenzymes represent a broad class of enzymes that catalyze oxidation-reduction (redox) reactions using molecular oxygen as the final electron acceptor. These enzymes contain flavin cofactors—either flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN)—which are essential for their catalytic activity. The term "aerobic" refers to their use of O₂ in the catalytic cycle, distinguishing them from anaerobic dehydrogenases. They participate in diverse biological processes: oxidation of alcohols and amines, desaturation reactions leading to olefin formation, aromatic hydroxylations, activation and reduction of O₂ for various biosynthetic pathways. These activities place them at critical junctions in metabolic networks such as energy production, detoxification, biosynthesis of natural products, and defense mechanisms in microorganisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aerobic Dehydrogenases (Flavoenzymes).